If you are an ASTM Compass Subscriber and this document is part of your subscription, you can access it for free at ASTM Compass
    ASTM D6398 - 08(2014)

    Standard Practice to Enhance Identification of Drug Names on Labels

    Active Standard ASTM D6398 | Developed by Subcommittee: F02.50

    Book of Standards Volume: 15.10

      Format Pages Price  
    PDF 3 $46.00   ADD TO CART
    Hardcopy (shipping and handling) 3 $46.00   ADD TO CART

    Significance and Use

    4.1 Medication errors occur when users are confused by the similar size, shape, color, typeface, and layout of labels that are used for a range of a manufacturer's drugs with widely dissimilar actions or potencies. The human visual system uses shape, size, color, and typeface in the initial recognition of a labeled drug. (See 9.1 – 9.3.) The use of this human visual system has been described in 21 CFR 429.12 for the labeling of insulin. Using the similar label design, color, and typeface throughout a product line makes identifying an individual drug more difficult.

    4.2 The objective of this practice is to provide guidance for the design of drug labels which will enable users to easily distinguish between drugs of differing action or potency. See Note 1.

    Note 1For specific requirements for these labels and other features of labels for OTC human drugs, see 21 CFR 201.66.

    1. Scope

    1.1 This practice covers the shape, size, color, layout, typeface, and barcoding on drug container labels intended for prescription product packaging such as might be used in hospitals, pharmacies, and nursing centers.

    1.1.1 This practice does not apply to bulk product shipping containers; in-process transfer containers; or primary, secondary, or tertiary finished goods containers.

    1.2 This practice does not apply to over-the-counter drug product labeling.

    1.3 This practice does not apply to retail product labeling.

    1.4 The values stated in SI units are to be regarded as standard. The values given in parentheses are for information only.

    2. Referenced Documents (purchase separately) The documents listed below are referenced within the subject standard but are not provided as part of the standard.

    Other Documents

    21 CFR 201.66 Format and Content Requirements for Over-the-Counter (OTC) Drug Product Labeling

    21 CFR 429.12 Packaging and Labeling of Insulin Available from Standardization Documents Order Desk, DODSSP, Bldg. 4, Section D, 700 Robbins Ave., Philadelphia, PA 19111-5098, http://www.dodssp.daps.mil.

    ISO 3864 Safety Colors and Safety Signs Available from American National Standards Institute (ANSI), 25 W. 43rd St., 4th Floor, New York, NY 10036, http://www.ansi.org.

    ASTM Standards

    D996 Terminology of Packaging and Distribution Environments

    D4267 Specification for Labels for Small-Volume (100 mL or Less) Parenteral Drug Containers

    D4774 Specification for User Applied Drug Labels in Anesthesiology

    D7298 Test Method for Measurement of Comparative Legibility by Means of Polarizing Filter Instrumentation

    ICS Code

    ICS Number Code 11.120.10 (Medicaments); 35.040 (Character sets and information coding)

    UNSPSC Code

    UNSPSC Code 55121609(Packaging labels)

    Referencing This Standard
    Link Here
    Link to Active (This link will always route to the current Active version of the standard.)

    DOI: 10.1520/D6398-08R14

    Citation Format

    ASTM D6398-08(2014), Standard Practice to Enhance Identification of Drug Names on Labels, ASTM International, West Conshohocken, PA, 2014, www.astm.org

    Back to Top